Vasculitis & polymyalgia rheumatica
Biologics in peripheral ulcerative keratitis
Authors' conclusion
Overall, whilst the evidence base for biologic use in PUK was poor, reported cases demonstrate an increasingly powerful and effective role for biologics in refractory PUK.
Study context
- Population
- Patients with peripheral ulcerative keratitis (PUK) treated with a biologic, reported in peer-reviewed articles (Medline, Embase, Cochrane Database of Systematic Reviews)
Methodological detailsLiterature search across Medline, Embase and Cochrane Database of Systematic Reviews
- Literature search across Medline, Embase and Cochrane Database of Systematic Reviews
Main finding
As reported in the abstract
- Evidence base for biologic use in PUK poor; reported cases show an increasingly powerful and effective role for biologics in refractory PUK
- Particularly RTX in PUK secondary to GPA
Original publication
Biologics in peripheral ulcerative keratitis. Semin Arthritis Rheum. Published 26 September 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →